BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 36172036)

  • 1. Metabolomics Reveals Dysregulated Sphingolipid and Amino Acid Metabolism Associated with Chronic Obstructive Pulmonary Disease.
    Kim J; Suresh B; Lim MN; Hong SH; Kim KS; Song HE; Lee HY; Yoo HJ; Kim WJ
    Int J Chron Obstruct Pulmon Dis; 2022; 17():2343-2353. PubMed ID: 36172036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma sphingolipids associated with chronic obstructive pulmonary disease phenotypes.
    Bowler RP; Jacobson S; Cruickshank C; Hughes GJ; Siska C; Ory DS; Petrache I; Schaffer JE; Reisdorph N; Kechris K
    Am J Respir Crit Care Med; 2015 Feb; 191(3):275-84. PubMed ID: 25494452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Occupational exposure to vapor, gas, dust, or fumes and chronic airflow limitation, COPD, and emphysema: the Swedish CArdioPulmonary BioImage Study (SCAPIS pilot).
    Torén K; Vikgren J; Olin AC; Rosengren A; Bergström G; Brandberg J
    Int J Chron Obstruct Pulmon Dis; 2017; 12():3407-3413. PubMed ID: 29238185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted metabolomics identifies perturbations in amino acid metabolism that sub-classify patients with COPD.
    Ubhi BK; Cheng KK; Dong J; Janowitz T; Jodrell D; Tal-Singer R; MacNee W; Lomas DA; Riley JH; Griffin JL; Connor SC
    Mol Biosyst; 2012 Oct; 8(12):3125-33. PubMed ID: 23051772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Five-year Progression of Emphysema and Air Trapping at CT in Smokers with and Those without Chronic Obstructive Pulmonary Disease: Results from the COPDGene Study.
    Pompe E; Strand M; van Rikxoort EM; Hoffman EA; Barr RG; Charbonnier JP; Humphries S; Han MK; Hokanson JE; Make BJ; Regan EA; Silverman EK; Crapo JD; Lynch DA;
    Radiology; 2020 Apr; 295(1):218-226. PubMed ID: 32013794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Malnutrition, Airflow Limitation and Severe Emphysema are Risks for Exacerbation of Chronic Obstructive Pulmonary Disease in Japanese Subjects: A Retrospective Single-Center Study.
    Yamaya M; Usami O; Nakayama S; Tode N; Yamada A; Ito S; Omata F; Momma H; Funakubo M; Ichinose M
    Int J Chron Obstruct Pulmon Dis; 2020; 15():857-868. PubMed ID: 32368031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relative contributions of emphysema and airway remodelling to airflow limitation in COPD: Consistent results from two cohorts.
    Tho NV; Ryujin Y; Ogawa E; Trang le TH; Kanda R; Goto K; Yamaguchi M; Nagao T; Lan le TT; Nakano Y
    Respirology; 2015 May; 20(4):594-601. PubMed ID: 25788016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The objective evaluation of obstructive pulmonary diseases with spirometry.
    Ozkaya S; Dirican A; Tuna T
    Int J Chron Obstruct Pulmon Dis; 2016; 11():2009-15. PubMed ID: 27616884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationships between airflow obstruction and quantitative CT measurements of emphysema, air trapping, and airways in subjects with and without chronic obstructive pulmonary disease.
    Schroeder JD; McKenzie AS; Zach JA; Wilson CG; Curran-Everett D; Stinson DS; Newell JD; Lynch DA
    AJR Am J Roentgenol; 2013 Sep; 201(3):W460-70. PubMed ID: 23971478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of clinical features between non-smokers with COPD and smokers with COPD: a retrospective observational study.
    Zhang J; Lin XF; Bai CX
    Int J Chron Obstruct Pulmon Dis; 2014; 9():57-63. PubMed ID: 24426780
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bronchoalveolar Lavage Fluid from COPD Patients Reveals More Compounds Associated with Disease than Matched Plasma.
    Halper-Stromberg E; Gillenwater L; Cruickshank-Quinn C; O'Neal WK; Reisdorph N; Petrache I; Zhuang Y; Labaki WW; Curtis JL; Wells J; Rennard S; Pratte KA; Woodruff P; Stringer KA; Kechris K; Bowler RP
    Metabolites; 2019 Jul; 9(8):. PubMed ID: 31349744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New Method for Combined Quantitative Assessment of Air-Trapping and Emphysema on Chest Computed Tomography in Chronic Obstructive Pulmonary Disease: Comparison with Parametric Response Mapping.
    Hwang HJ; Seo JB; Lee SM; Kim N; Yi J; Lee JS; Lee SW; Oh YM; Lee SD
    Korean J Radiol; 2021 Oct; 22(10):1719-1729. PubMed ID: 34269529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The identification of novel stroke-related sphingolipid biomarkers using UPLC-MS/MS.
    Yang Z; Deng X; Zhu J; Chen S; Jiao C; Ruan Y
    Clin Chim Acta; 2024 Jan; 552():117652. PubMed ID: 37979606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative computed tomography measurements of emphysema for diagnosing asthma-chronic obstructive pulmonary disease overlap syndrome.
    Xie M; Wang W; Dou S; Cui L; Xiao W
    Int J Chron Obstruct Pulmon Dis; 2016; 11():953-61. PubMed ID: 27226711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship Between Emphysema Severity and the Location of Lung Cancer in Patients With Chronic Obstructive Lung Disease.
    Lim J; Shin KM; Lee K; Lim JK; Kim HJ; Cho SH; Cha SI
    AJR Am J Roentgenol; 2015 Sep; 205(3):540-5. PubMed ID: 26295639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contribution of CT quantified emphysema, air trapping and airway wall thickness on pulmonary function in male smokers with and without COPD.
    Mohamed Hoesein FA; de Jong PA; Lammers JW; Mali WP; Mets OM; Schmidt M; de Koning HJ; Aalst Cv; Oudkerk M; Vliegenthart R; Ginneken Bv; van Rikxoort EM; Zanen P
    COPD; 2014 Sep; 11(5):503-9. PubMed ID: 25093696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative CT detects progression in COPD patients with severe emphysema in a 3-month interval.
    Konietzke P; Wielpütz MO; Wagner WL; Wuennemann F; Kauczor HU; Heussel CP; Eichinger M; Eberhardt R; Gompelmann D; Weinheimer O
    Eur Radiol; 2020 May; 30(5):2502-2512. PubMed ID: 31965260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ventilation/perfusion SPECT in chronic obstructive pulmonary disease: an evaluation by reference to symptoms, spirometric lung function and emphysema, as assessed with HRCT.
    Jögi J; Ekberg M; Jonson B; Bozovic G; Bajc M
    Eur J Nucl Med Mol Imaging; 2011 Jul; 38(7):1344-52. PubMed ID: 21365251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlations of Computed Tomography Measurement of Distal Pulmonary Vascular Pruning with Airflow Limitation and Emphysema in COPD Patients.
    Tang G; Wang F; Liang Z; Liang C; Wang J; Yang Y; Tang W; Shi W; Tang G; Yang K; Wang Z; Li Q; Li H; Xu J; Chen D; Chen R
    Int J Chron Obstruct Pulmon Dis; 2022; 17():2241-2252. PubMed ID: 36128016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of the Emphysema Index Combined with the Chronic Obstructive Pulmonary Disease Assessment Test Score in the Evaluation of Chronic Obstructive Pulmonary Disease.
    Ding Q; Wei X; Li J; Gao YZ; Xu SD; Yu N; Mi JY; Mi BB; Guo YM
    Can Respir J; 2021; 2021():9996305. PubMed ID: 34691315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.